Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Treace Medical Concepts (TMCI) Return on Capital Employed (2021 - 2026)

Treace Medical Concepts filings provide 5 years of Return on Capital Employed readings, the most recent being 33.23% for Q4 2025.

  • On a quarterly basis, Return on Capital Employed fell 231.0% to 33.23% in Q4 2025 year-over-year; TTM through Dec 2025 was 33.23%, a 231.0% decrease, with the full-year FY2025 number at 31.27%, down 336.0% from a year prior.
  • Return on Capital Employed hit 33.23% in Q4 2025 for Treace Medical Concepts, down from 30.16% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 2.1% in Q1 2021 to a low of 34.36% in Q3 2024.
  • Median Return on Capital Employed over the past 5 years was 26.45% (2022), compared with a mean of 22.72%.
  • Biggest five-year swings in Return on Capital Employed: tumbled -2173bps in 2022 and later surged 503bps in 2025.
  • Treace Medical Concepts' Return on Capital Employed stood at 13.65% in 2021, then plummeted by -100bps to 27.33% in 2022, then grew by 6bps to 25.57% in 2023, then dropped by -21bps to 30.92% in 2024, then dropped by -7bps to 33.23% in 2025.
  • The last three reported values for Return on Capital Employed were 33.23% (Q4 2025), 30.16% (Q3 2025), and 29.16% (Q2 2025) per Business Quant data.